Emyria MD Michael Winlo Tells JustStocks Second Specialist has Been Approved for MDMA-Assisted Therapy Program

Emyria Limited (ASX: EMD) MD Michael Winlo speaks with JustStocks Video following the news the company’s first female psychiatry specialist has been granted “Authorised Prescriber” status by the Therapeutic Goods Administration (TGA). He says Emyria’s second AP is understood to be the first, and currently only, female Authorised Prescriber for MDMA-assisted therapy in Australia. Emyria’s been granted approval to prescribe MDMA for the treatment of Post-Traumatic Stress Disorder (PTSD). PTSD affects approximately a million Australians with up to one third of patients failing to benefit from conventional therapies.

Articles of Interest